Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials

Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials

Non-vitamin K antagonist oral anticoagulants (NOACs) have a half-life of around 12 h. We aimed to clarify if there was any effect modification by dosing (once- or twice-daily) regimens in Asian patients. Methods: Phase III randomized controlled trials of NOACs compared with warfarin in Asian patient...

Full description

Bibliographic Details
Main Authors: Kang-Ling Wang, Chun-Chih Chiu, Doreen Su-Yin Tan, Chun-Yi Lin, En-Yu Lai, Shinya Goto, Robert P. Giugliano, Chern-En Chiang
Format: Article
Language:English
Published: Elsevier 2017-08-01
Series:Journal of the Formosan Medical Association
Subjects:
Asian patients
Atrial fibrillation
Non-vitamin K antagonist oral anticoagulants
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664617301468

Internet

http://www.sciencedirect.com/science/article/pii/S0929664617301468

Similar Items